Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

NCT00979420 ·Status: COMPLETED

Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients

NCT02184299 ·Status: COMPLETED ·Phase: PHASE4

Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients

NCT02184078 ·Status: COMPLETED ·Phase: PHASE4

A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine

NCT00344461 ·Status: COMPLETED ·Phase: PHASE4

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults

NCT02182765 ·Status: TERMINATED ·Phase: PHASE1

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

NCT00081588 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.

NCT00967187 ·Status: COMPLETED ·Phase: PHASE2

A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female Volunteers

NCT01268839 ·Status: COMPLETED ·Phase: PHASE1

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

NCT00255099 ·Status: COMPLETED ·Phase: PHASE3

Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients

NCT04303598 ·Status: UNKNOWN ·Phase: PHASE3

The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine

NCT00002381 ·Status: COMPLETED ·Phase: PHASE1

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

NCT01524900 ·Status: COMPLETED

TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial

NCT00111280 ·Status: COMPLETED ·Phase: PHASE2

Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected Subjects

NCT02194179 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.

NCT00002115 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

NCT07202546 ·Status: RECRUITING ·Phase: PHASE2

Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

NCT00634959 ·Status: COMPLETED ·Phase: PHASE2

Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive

NCT01489046 ·Status: TERMINATED ·Phase: PHASE2

A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.

NCT00905489 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy

NCT01844297 ·Status: UNKNOWN ·Phase: NA

Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study

NCT05295394 ·Status: WITHDRAWN ·Phase: PHASE4

VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients

NCT00561925 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials

NCT02187107 ·Status: COMPLETED ·Phase: PHASE2

Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric Patients

NCT00273975 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

NCT00799864 ·Status: COMPLETED ·Phase: PHASE2